Quest Diagnostics Incorporated DGX

236.32 (0.27) (0.11%) as of 25 Sep
Market cap
$26.2B
P/E
24.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Quest Diagnostics Incorporated (DGX) Operating margin

Quest Diagnostics Incorporated's operating margin over the twelve months to 30 June 2026 was 14.1%, down 0.0 percentage points from fiscal 2025 (14.1%). Over the past ten years it has ranged from 13.6% (fiscal 2024) to 22.1% (fiscal 2021); the current reading is higher than 27% of that period. That is above the Diagnostics & Research industry median of −8.57% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 14.1% 0.47
FY2024 13.6% (0.01)
FY2023 13.6% (0.81)
FY2022 14.5% (7.62)
FY2021 22.1% 1.18
FY2020 20.9% 4.96
FY2019 15.9% 1.31
FY2018 14.6% (1.12)
FY2017 15.7% (1.96)
FY2016 17.7% (0.97)

Quarterly

Period Operating margin Change (points)
Jun 2026 15.1% 1.30
Mar 2026 13.8% 0.02
Dec 2025 13.8% 0.05
Sep 2025 13.7% (2.15)
42 more quarters

Against its own ten years

Low 13.6% High 22.1%
Ten-year median 15.7%
Current reading's percentile 27

Operating margin against peers

Company Operating margin
IDXX IDEXX Laboratories, Inc. compare 32.0%
MTD Mettler-Toledo International, Inc. compare 28.4%
MEDP Medpace Holdings, Inc. compare 21.0%
ILMN Illumina, Inc. compare 19.7%
DGX Quest Diagnostics Incorporated 14.1%
RVTY Revvity Inc. compare 12.3%
LH Labcorp Holdings Inc. compare 10.4%
WAT Waters Corporation compare 7.10%
GH Guardant Health, Inc. compare −39.8%
Diagnostics & Research industry median −8.57%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on DGX